Approval · Notice of Compliance 35819 · 2025
JULUCA: Notice of Compliance 35819
Issued August 11, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35819
- Date
- August 11, 2025
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production. Change in the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JULUCA | Not yet assigned | — |
Medicinal ingredients
- RILPIVIRINE HYDROCHLORIDE 25 MG per TAB
- DOLUTEGRAVIR SODIUM 50 MG per TAB